Catalio Capital Management LP, a multi-strategy life sciences investment firm with over $1 billion in assets under management, has launched its public equities hedge fund investment strategy focused on identifying life science investment opportunities.

In connection with the launch of the vehicle, the investment team from HealthCor Management, a healthcare hedge fund, along with members of its operations, financial, administrative and marketing divisions, have agreed to join Catilio to help build out the strategy. HealthCor’s founders, Art Cohen and Joe Healey, will join the firm as senior advisors.

“Launching Catalio’s Public Equities strategy and adding experienced public equities investors to our team will significantly augment our capabilities in support of this goal and complement our robust private equity, credit and special situations strategies,” comments George Petrocheilos, co-founder and managing partner of Catalio.